Question The Comirnaty vaccine to be retracted?
First we have to ask the question: Is there a pandemia?
WHO seems to lack a definition of a Pandemia. At least Google and I are unable to find a proper definition of a pandemia. Without a definition there is no pandemia.
Second question:How do we know that the mRNA in the Covid-19 vaccine Comirnaty is coding for the spike protein?
EDA and FDA have to check the mRNA strings that are in the vaccine by sequencing the RNA in aan adequate number of vaccine bottles.
According to the information on the Swedish MPA website the vaccine has a lower amount of mRNA and a higher amount of smaller RNA molecules than in the vaccine tested in trials.
This means the vaccine is different from the from the trial vaccine.
This means that the vaccine has to be retracted as unsafe until the RNA code is verified and that all the smaller RNA contaminating strings are characterized and are purified away from the vaccine
Then you have to ask about the nucleotide code of the mRNA. Is it the exact same nucleotide sequence as in the already sequenced viral RNA coding for spike protein ?
Or is it a slightly changed code coding for another protein or a totally changed mRNA coding for another totally unknown protein, or a hormone or some totally different protein?
The intracellular ribosomes just make the protein that’s coded in the mRNA
The EDA and FDA hav to check the vaccine at least each lot in enough numbers of vials to be sure there is just the mRNA coding for the spike protein and nothing else.
Next problem is
Who benefits from the Comirnaty vaccine?
To me it seems to be WHO, not any ordinary world citizen.
When reading the info from EMA about the content of the Comirnaty vaccine you first have to find the right page on the EMA site.
https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty#product-information-section
Then you have to find the product information page
https://www.ema.europa.eu/documents/product-information/comirnaty-epar-product-information_en.pdf
Then it says that the dose is essentially free from potassium an sodium.
Each dose contains ”less than 1 mmol potassium (39 mg) per dose, that is to say essentially ‘potassium-free’. This vaccine contains ”less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.”
Note the quotation marks around that is to say essentially ‘sodium-free’
To get the concentration of potassium and sodium we have to know what is the volume of the vaccine.
Concentration is amount of potassium or sodium per volume.
The volume per dose is according to the instructions 0.3 mL. ” Comirnaty is given after dilution as an injection of 0.3 mL into a muscle of your upper arm. ”
Normal physiological saline i 141 mmol/L which means the sodium concentration in the extracellular fluid of sodium is 3.2 g per liter, 3.2 g/L
Comirnaty has 23 mg of sodium per dose of 0.3 mL.
In milligrams the concentration will be 23 mg / 0.3 mL = 76.666 g/L
If we then compare the concentration of sodium in extracellular fluid of 3.2 g/L by the concentration of sodium in the vaccine 77.667 g/L we find that the vaccine contains about 24 times higher concentration of sodium than in the body.
Or if we like to compare mmol/L instead of grams per liter we’ll get the same result
Comirnaty has a sodium content of 1 mmol/0.3 mL = 3.333 mol/L or 3 333 mmol/L
The extracellular fluid has sodium content of 141 mmol/L.
3 333 mmol/L / 141 mmol/L = 23.638 ~24 times higher concentration of sodium in the vaccine than in the body fluids.
And it is the same with the potassium. But even worse.
Comirnaty has a potassium content of 1 mmol/0.3 mL = 3.333 mol/L or 3 333 mmol/L
The extracellular fluid has 4 mmol/L.
3 333 mmol/L / 4 mmol/L = more than 800 times higher concentration of potassium in the vaccine than in the extracellular fluid.
So the total potassium and sodium concentration will locally be up to 800 respectively 24 times higher than the concentration of potassium and sodium in normal extracellular fluid. No wonder tha the side effect is ”Very common side effects: may affect more than 1 in 10 people • injection site: pain, swelling”
But this also implies that the vaccine is NOT ”that is to say essentially ‘potassium-free’ ” nor ”that is to say essentially ‘sodium-free’ ”.
I totally understand the quotation marks around ‘potassium-free’ and‘sodium-free’because tthose statements are blatant lies and the EDA and FDA seem to lack the competence to handle basic concentration arithmetics.
As a molecular biologist been working with RNA and DNA I fully understand that the high salt concentrations are required to prevent self annealing, that the mRNA is folding back in hairpin loops like in t-RNA, those RNA molecules that transfer single amino acids to ribosomes to build a new protein.
The concentration of potassium and sodium at the injection site will destroy and even kill the cells immersed in the injection fluid.
We are asking the questions, they are very important and the authorities have to prove us wrong
Östervåla, Sweden 2021-01-03
Björn Hammarskjöld
Assistant professor in Pediatrics at Strömstad Academy
Former Chief in Pediatrics
Ph.D. in Biochemistry at Stockholm University
Virologist and Molecular biologist with more than 10 years of lab experience
References
https://www.ema.europa.eu/documents/product-information/comirnaty-epar-product-information_en.pdf
Comirnaty contains potassium and sodium This vaccine contains less than 1 mmol potassium (39 mg) per dose, that is to say essentially ‘potassium-free’. This vaccine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.
3. How Comirnaty is given
Comirnaty is given after dilution as an injection of 0.3 mL into a muscle of your upper arm. You will receive 2 injections, given at least 21 days apart. After the first dose of Comirnaty, you should receive a second dose of the same vaccine after 21 days to complete the vaccination course. If you have any further questions on the use of Comirnaty, ask your doctor, pharmacist or nurse.
4. Possible side effects Like all vaccines, Comirnaty can cause side effects, although not everybody gets them.
Very common side effects: may affect more than 1 in 10 people • injection site: pain, swelling • tiredness • headache • muscle pain • joint pain • chills, fever
Common side effects: may affect up to 1 in 10 people • injection site redness • nausea
Uncommon side effects: may affect up to 1 in 100 people • enlarged lymph nodes • feeling unwell 26 • pain in limb • insomnia • injection site itching
Rare side effects: may affect up to 1 in 1,000 people • temporary one sided facial drooping
Not known (cannot be estimated from the available data) • severe allergic reaction
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V and include batch/Lot number if available. By reporting side effects you can help provide more information on the safety of this medicine.